Stephen L. Gwaltney

2.0k citations

25 papers · 1.3k indexed · h-index 17

Endocrinology, Diabetes and Metabolism top 5%
- Diabetes Treatment and Management 6
Organic Chemistry top 5%
Oncology top 10%
- Peptidase Inhibition and Analysis 7
- Cancer Treatment and Pharmacology 4
- Cancer-related Molecular Pathways 4
Cellular and Molecular Neuroscience top 10%
- Neuropeptides and Animal Physiology 6
Molecular Biology
- Biochemical and Molecular Research 3
- DNA Repair Mechanisms 2
Cell Biology
- Hippo pathway signaling and YAP/TAZ 4

Co-authors: William Roush Elizabeth Hansell R.J. Skene Lihong Shi Zhiyuan Zhang Rongda Xu Daniel B. Kassel Michael B. Wallace
Cited by: Endocrinology, Diabetes and Metabolism Organic Chemistry Oncology
Journals: Journal of the American Chemical Society (1 paper)Cancer Research (1 paper)Journal of Medicinal Chemistry (3 papers)
Partner nations: United States United Kingdom Japan

In The Last Decade

Stephen L. Gwaltney

25 papers receiving 1.2k citations

Peers

Countries citing papers authored by Stephen L. Gwaltney

Since Specialization

Citations

This map shows the geographic impact of Stephen L. Gwaltney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen L. Gwaltney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen L. Gwaltney more than expected).

Fields of papers citing papers by Stephen L. Gwaltney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen L. Gwaltney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen L. Gwaltney. The network helps show where Stephen L. Gwaltney may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Stephen L. Gwaltney, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stephen L. Gwaltney Line = papers co-authored together Stephen L. Gwaltney links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Targeting YAP/TAZ-TEAD signaling as a therapeutic approach in head and neck squamous cell carcinoma Cancer Letters ·Kuniaki Sato,Farhoud Faraji,Rodolfo Daniel Cervantes‐Villagrana,Xingyu Wu,Keiichi Koshizuka,Tomohiko Ishikawa,Ramiro Iglesias‐Bartolomé,Lei Chen,Paula L. Miliani de Marval,Stephen L. Gwaltney,Benjamin A. Adler,J. Silvio Gutkind	2025	6
2	39 (PB027): TEAD inhibition by SW-682 potentiates activity of targeted therapies in NSCLC models European Journal of Cancer ·L. Chen,Veronica Jové,Paula Miliani de Marval,Robert DuBose,Sandeep Saha,Mark P. Johnson,Sungwoo Ahn,Kristen Gilmore Powell,Fengyi Liu,Brian G. Lawhorn,Stephen L. Gwaltney,Wei Shao,Timothy A. Lin	2024	1
3	234 (PB222): Rational combination of pan-TEAD inhibitor SW-682 and MEK inhibitor mirdametinib in head and neck squamous cell carcinomas leads to synergistic response European Journal of Cancer ·Anke Schirmer,Lei Chen,Luigi Celentano,Alma Rosa Chanelo,Veronica Jové,Robert DuBose,Supriya K. Saha,Mark P. Johnson,Brian G. Lawhorn,Stephen L. Gwaltney,Timothy A. Lin,Paula Miliani de Marval	2024	1
4	Discovery of potent and orally active 1,4-disubstituted indazoles as novel allosteric glucokinase activators Bioorganic & Medicinal Chemistry Letters ·Zacharia S. Cheruvallath,Stephen L. Gwaltney,M. Sabat,Mingnam Tang,Haixia Wang,Andy Jennings,David J. Hosfield,Bumsup Lee,Yiqin Wu,Petro Halkowycz,Charles E. Grimshaw	2017	15
5	Design, synthesis and SAR of novel glucokinase activators Bioorganic & Medicinal Chemistry Letters ·Zacharia S. Cheruvallath,Stephen L. Gwaltney,M. Sabat,Mingnam Tang,Jun Feng,Haixia Wang,Joanne Miura,Prasuna Guntupalli,Andy Jennings,David J. Hosfield,Bumsup Lee,Yiqin Wu	2013	27
6	Structure-based design of pyridopyrimidinediones as dipeptidyl peptidase IV inhibitors Bioorganic & Medicinal Chemistry Letters ·Betty Lam,Zhiyuan Zhang,Jeffery A. Stafford,R.J. Skene,Lihong Shi,Stephen L. Gwaltney	2012	21
7	Structure-based design and synthesis of benzimidazole derivatives as dipeptidyl peptidase IV inhibitors Bioorganic & Medicinal Chemistry Letters ·Michael B. Wallace,Jun Feng,Zhiyuan Zhang,R.J. Skene,Lihong Shi,Christopher L. Caster,Daniel B. Kassel,Rongda Xu,Stephen L. Gwaltney	2008	50
8	Medicinal Chemistry Approaches to the Inhibition of Dipeptidyl Peptidase IV Current Topics in Medicinal Chemistry ·Stephen L. Gwaltney	2008	22
9	Discovery of 1,4-dihydroindeno[1,2-c]pyrazoles as a novel class of potent and selective checkpoint kinase 1 inhibitors Bioorganic & Medicinal Chemistry ·Yunsong Tong,Akiyo Claiborne,Kent D. Stewart,Chang Park,Peter Kovar,Zehan Chen,R.B. Credo,Wen‐Zhen Gu,Stephen L. Gwaltney,Russell A. Judge,Haiying Zhang,Saul H. Rosenberg,Hing L. Sham,Thomas J. Sowin,Nan‐Horng Lin	2007	33
10	Discovery of Alogliptin: A Potent, Selective, Bioavailable, and Efficacious Inhibitor of Dipeptidyl Peptidase IV Journal of Medicinal Chemistry ·Jun Feng,Zhiyuan Zhang,Michael B. Wallace,Jeffrey A. Stafford,Stephen W. Kaldor,Daniel B. Kassel,Marc Navre,Lihong Shi,R.J. Skene,Tomoko Asakawa,Koji Takeuchi,Rongda Xu,David R. Webb,Stephen L. Gwaltney	2007	326
11	Synthesis and biological evaluation of 1-(2,4,5-trisubstituted phenyl)-3-(5-cyanopyrazin-2-yl)ureas as potent Chk1 kinase inhibitors Bioorganic & Medicinal Chemistry Letters ·Gaoquan Li,Lisa Hasvold,Zhi‐Fu Tao,Gary T. Wang,Stephen L. Gwaltney,Jyoti Patel,Peter Kovar,R.B. Credo,Zehan Chen,Haiying Zhang,Chang Park,Hing L. Sham,Thomas J. Sowin,Saul H. Rosenberg,Nan‐Horng Lin	2006	29
12	Synthesis and activity of 1-aryl-1′-imidazolyl methyl ethers as non-thiol farnesyltransferase inhibitors Bioorganic & Medicinal Chemistry Letters ·Qun Li,Gary T. Wang,Tongmei Li,Stephen L. Gwaltney,Keith W. Woods,Akiyo Claiborne,Xilu Wang,Wendy Gu,Jerry D. Cohen,Vincent S. Stoll,Charles W. Hutchins,David J. Frost,Saul H. Rosenberg,Hing L. Sham	2004	10
13	Pyridone-Containing farnesyltransferase inhibitors: synthesis and biological evaluation Bioorganic & Medicinal Chemistry Letters ·Lisa Hasvold,Weibo Wang,Stephen L. Gwaltney,Todd W. Rockway,Lissa T.J. Nelson,Robert A. Mantei,Stephen A. Fakhoury,Gerard M. Sullivan,Qun Li,Nan‐Horng Lin,Le Wang,Haiying Zhang,Jerome Cohen,Wen‐Zhen Gu,Kennan C. Marsh,Joy Bauch,Saul H. Rosenberg,Hing L. Sham	2003	64
14	Stereoselective synthesis of an advanced taxusin intermediate: an application of the type 2 intramolecular Diels–Alder reaction Tetrahedron Letters ·Markian M. Stec,Stephen L. Gwaltney,L. D. Burke,Ha Nguyen,Kenneth J. Shea	2003	2
15	Active site mapping, biochemical properties and subcellular localization of rhodesain, the major cysteine protease of Trypanosoma brucei rhodesiense Molecular and Biochemical Parasitology ·Conor R. Caffrey,Elizabeth Hansell,Kimberley D. Lucas,Linda S. Brinen,Alejandro Álvarez Hernández,Jiamning Cheng,Stephen L. Gwaltney,William Roush,York‐Dieter Stierhof,Matthew Bogyo,Dietmar Steverding,James H. McKerrow	2001	150
16	Novel sulfonate Derivatives: potent antimitotic agents Bioorganic & Medicinal Chemistry Letters ·Stephen L. Gwaltney,Hovis Imade,Qun Li,Laura Gehrke,R.B. Credo,Robert B. Warner,Jang Yun Lee,Peter Kovar,David J. Frost,Shi-Chung Ng,Hing L. Sham	2001	18
17	Novel sulfonate analogues of combretastatin A-4 Bioorganic & Medicinal Chemistry Letters ·Stephen L. Gwaltney,Hovis Imade,Kenneth J. Barr,Qun Li,Laura Gehrke,R.B. Credo,Robert B. Warner,Jang Yun Lee,Peter Kovar,Jieyi Wang,Michael A. Nukkala,N A Zielinski,David J. Frost,Shi-Chung Ng,Hing L. Sham	2001	49
18	Vinyl Sulfonate Esters and Vinyl Sulfonamides: Potent, Irreversible Inhibitors of Cysteine Proteases Journal of the American Chemical Society ·William Roush,Stephen L. Gwaltney,Jianming Cheng,Karl A. Scheidt,James H. McKerrow,Elizabeth Hansell	1998	193
19	Bridged to fused ring interchange. The total synthesis of (±)-ledol Tetrahedron Letters ·Stephen L. Gwaltney,Kenneth J. Shea	1996	20
20	Bridged to Fused Ring Interchange. Methodology for the Construction of Fused Cycloheptanes and Cyclooctanes. Total Syntheses of Ledol, Ledene, and Compressanolide The Journal of Organic Chemistry ·Stephen L. Gwaltney,Steven T. Sakata,Kenneth J. Shea	1996	47

About Stephen L. Gwaltney

Stephen L. Gwaltney is a scholar working on Oncology, Endocrinology, Diabetes and Metabolism and Cellular and Molecular Neuroscience, having authored 25 papers that have together received 1.3k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (7 papers), Diabetes Treatment and Management (6 papers), Neuropeptides and Animal Physiology (6 papers), Cancer Treatment and Pharmacology (4 papers), Hippo pathway signaling and YAP/TAZ (4 papers), Cancer-related Molecular Pathways (4 papers), Biochemical and Molecular Research (3 papers) and DNA Repair Mechanisms (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (350 citations), Organic Chemistry (540 citations) and Oncology (391 citations). Stephen L. Gwaltney has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include William Roush, Elizabeth Hansell, R.J. Skene, Lihong Shi, Zhiyuan Zhang, Rongda Xu, Daniel B. Kassel, Michael B. Wallace, Karl A. Scheidt and James H. McKerrow. Their work appears in journals such as Journal of the American Chemical Society, Cancer Research and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact